Alexion Pharmaceuticals, Inc.

Forvis Mazars Wealth Advisors, LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

7/14/2021

Shares

12,329

Value ($000)

2,265

Weight

0.1%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	7/14/2021	2,265	0.1%	12,329	6/30/2021
2021 Q1	4/23/2021	2,262	0.1%	14,793	3/31/2021
2020 Q4	1/22/2021	2,420	0.1%	15,487	12/31/2020
2020 Q3	11/5/2020	1,732	0.1%	15,139	9/30/2020
2020 Q2	7/15/2020	1,547	0.1%	13,786	6/30/2020
2020 Q1	4/10/2020	938	0.1%	10,450	3/31/2020
2019 Q4	1/13/2020	480	0.0%	4,436	12/31/2019